{"id":"W4232137107","doi":"10.3310/hta15suppl1-02","title":"Omalizumab for the treatment of severe persistent allergic asthma in children aged 6–11 years","year":2011,"lang":"en","type":"article","venue":"Health Technology Assessment","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Health Technology Assessment Programme; Hospital for Sick Children","keywords":"Omalizumab; Medicine; Nice; Asthma; Quality-adjusted life year; Cost effectiveness; Population; Quality of life (healthcare); Incremental cost-effectiveness ratio; Pediatrics; Economic evaluation; European union; Intensive care medicine; Internal medicine; Environmental health","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003954624,0.0006829252,0.002320532,0.001531193,0.0001670891,0.00116799,0.0006369338,0.00118712,0.002089545],"category_scores_gemma":[0.00854745,0.0003398384,0.006619295,0.001165251,0.0002152665,0.0007692644,0.0004602171,0.001214753,0.0003008724],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001547043,"about_ca_system_score_gemma":0.001980797,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003692285,"about_ca_topic_score_gemma":0.0087367,"domain_scores_codex":[0.997063,0.001515583,0.0005741104,0.0001644843,0.0005591069,0.0001236841],"domain_scores_gemma":[0.9963851,0.002408539,0.000902042,0.00004207572,0.000192115,0.00007022568],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"systematic_review","study_design_scores_codex":[0.01226299,0.0002010276,0.006921133,0.3369118,0.02971223,0.0006481172,0.000155591,0.003002661,0.001467194,0.002760174,0.01700198,0.5889551],"study_design_scores_gemma":[0.02631311,0.01188695,0.09081386,0.4199611,0.1527418,0.004594551,0.0004148285,0.003164284,0.002941353,0.004008877,0.2829356,0.000223694],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.006211773,0.9898315,0.0002329304,0.001236021,0.0003095373,0.000186772,0.0006225083,0.000009410704,0.00135952],"genre_scores_gemma":[0.1120264,0.8814321,0.002609243,0.001627218,0.0004291598,0.0003287305,0.0008798565,0.000008828625,0.0006584778],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003954624,"threshold_uncertainty_score":0.02091426,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0313187190121669,"score_gpt":0.3288826945952632,"score_spread":0.2975639755830963,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}